β-nicotinamide mononucleotide reduced form disodium salt(NMNH)

Founded in 2018, WeiTai BioPharmaceutical Co.,Ltd(Hangzhou ) is a high-tech enterprise with synthetic biotechnology as the base, enzyme process and fermentation as the core, and the addition of large health functional food and cosmetic raw materials as the direction of industrialization. At present, the company has its own huge enzyme library and hundreds of gene strains (including enzyme engineering, strain engineering, biocatalytic engineering, fermentation engineering, as well as the full series of nucleotides, deoxidation series, poly-phosphate series), and takes the lead in applying biosynthesis technology to the commercial production of "life molecules" catalyzed by nucleotides and biological enzymes as monomers. The application of its products covers eight fields such as biomedicine, nutrition and health, functional food, green agriculture, veterinary medicine, daily chemical care, cosmetics, and vaccine diagnostic reagents. It is one of the leading enterprises in large-scale production and technology in the field of synthetic biology in China. In 2018, the company was listed as a "high, new and sharp" key investment attraction project by Anhui Provincial Science and Technology Department. In December of the same year, Weitai Pharmaceutical (Maanshan) Co., Ltd. was established as a production base, located in Maanshan Economic Development Zone; The first phase of production is 70 million yuan. The park covers an area of 30 mu, with 4500 square meters of production workshop and 2500 square meters of research and development, office area; Purchase a large number of advanced production equipment and high-precision testing instruments and set up a strict and scientific quality management system; At the same time, it has absorbed many high-tech talents and experts in the field of synthetic biology, with a total investment of 110 million yuan.